Correlation Between Walker Dunlop and Aarti Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and Aarti Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and Aarti Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and Aarti Drugs Limited, you can compare the effects of market volatilities on Walker Dunlop and Aarti Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of Aarti Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and Aarti Drugs.

Diversification Opportunities for Walker Dunlop and Aarti Drugs

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Walker and Aarti is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and Aarti Drugs Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aarti Drugs Limited and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with Aarti Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aarti Drugs Limited has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and Aarti Drugs go up and down completely randomly.

Pair Corralation between Walker Dunlop and Aarti Drugs

Allowing for the 90-day total investment horizon Walker Dunlop is expected to under-perform the Aarti Drugs. But the stock apears to be less risky and, when comparing its historical volatility, Walker Dunlop is 1.67 times less risky than Aarti Drugs. The stock trades about -0.42 of its potential returns per unit of risk. The Aarti Drugs Limited is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest  39,945  in Aarti Drugs Limited on November 27, 2024 and sell it today you would lose (1,940) from holding Aarti Drugs Limited or give up 4.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.24%
ValuesDaily Returns

Walker Dunlop  vs.  Aarti Drugs Limited

 Performance 
       Timeline  
Walker Dunlop 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Walker Dunlop has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Aarti Drugs Limited 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Aarti Drugs Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Walker Dunlop and Aarti Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Walker Dunlop and Aarti Drugs

The main advantage of trading using opposite Walker Dunlop and Aarti Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, Aarti Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aarti Drugs will offset losses from the drop in Aarti Drugs' long position.
The idea behind Walker Dunlop and Aarti Drugs Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.